nodes	percent_of_prediction	percent_of_DWPC	metapath
Pranlukast—CYSLTR1—Montelukast—chronic obstructive pulmonary disease	0.359	0.767	CbGbCtD
Pranlukast—TNF—chronic obstructive pulmonary disease	0.355	1	CbGaD
Pranlukast—CYP2C9—Arformoterol—chronic obstructive pulmonary disease	0.02	0.0426	CbGbCtD
Pranlukast—CYP2C9—Formoterol—chronic obstructive pulmonary disease	0.02	0.0426	CbGbCtD
Pranlukast—CYP3A4—Salbutamol—chronic obstructive pulmonary disease	0.0153	0.0327	CbGbCtD
Pranlukast—CYP2C9—Montelukast—chronic obstructive pulmonary disease	0.0151	0.0323	CbGbCtD
Pranlukast—CYP3A4—Tiotropium—chronic obstructive pulmonary disease	0.0104	0.0221	CbGbCtD
Pranlukast—CYP3A4—Aminophylline—chronic obstructive pulmonary disease	0.00987	0.0211	CbGbCtD
Pranlukast—CYP3A4—Montelukast—chronic obstructive pulmonary disease	0.0088	0.0188	CbGbCtD
Pranlukast—RNASE3—respiratory system—chronic obstructive pulmonary disease	0.00595	0.102	CbGeAlD
Pranlukast—IL5—respiratory system—chronic obstructive pulmonary disease	0.00541	0.0927	CbGeAlD
Pranlukast—CYP3A4—Prednisolone—chronic obstructive pulmonary disease	0.00516	0.011	CbGbCtD
Pranlukast—RNASE3—bronchus—chronic obstructive pulmonary disease	0.0049	0.084	CbGeAlD
Pranlukast—CYP3A4—Prednisone—chronic obstructive pulmonary disease	0.00488	0.0104	CbGbCtD
Pranlukast—IL5—connective tissue—chronic obstructive pulmonary disease	0.00476	0.0816	CbGeAlD
Pranlukast—IL5—bronchus—chronic obstructive pulmonary disease	0.00445	0.0763	CbGeAlD
Pranlukast—MUC2—respiratory system—chronic obstructive pulmonary disease	0.00416	0.0713	CbGeAlD
Pranlukast—MUC2—connective tissue—chronic obstructive pulmonary disease	0.00366	0.0628	CbGeAlD
Pranlukast—RNASE3—lung—chronic obstructive pulmonary disease	0.00316	0.0542	CbGeAlD
Pranlukast—IL5—lung—chronic obstructive pulmonary disease	0.00287	0.0492	CbGeAlD
Pranlukast—NFKB1—respiratory system—chronic obstructive pulmonary disease	0.00237	0.0407	CbGeAlD
Pranlukast—CYSLTR1—respiratory system—chronic obstructive pulmonary disease	0.00233	0.0399	CbGeAlD
Pranlukast—MUC2—lung—chronic obstructive pulmonary disease	0.00221	0.0379	CbGeAlD
Pranlukast—NFKB1—connective tissue—chronic obstructive pulmonary disease	0.00209	0.0358	CbGeAlD
Pranlukast—NFKB1—bronchus—chronic obstructive pulmonary disease	0.00195	0.0335	CbGeAlD
Pranlukast—CYSLTR1—bronchus—chronic obstructive pulmonary disease	0.00192	0.0329	CbGeAlD
Pranlukast—CYSLTR1—smooth muscle tissue—chronic obstructive pulmonary disease	0.00188	0.0322	CbGeAlD
Pranlukast—NFKB1—trachea—chronic obstructive pulmonary disease	0.00175	0.03	CbGeAlD
Pranlukast—NFKB1—lung—chronic obstructive pulmonary disease	0.00126	0.0216	CbGeAlD
Pranlukast—CYSLTR1—lung—chronic obstructive pulmonary disease	0.00124	0.0212	CbGeAlD
Pranlukast—NFKB1—MAPK Signaling Pathway—IL1B—chronic obstructive pulmonary disease	4.54e-05	0.000387	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—ADRB2—chronic obstructive pulmonary disease	4.53e-05	0.000386	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	4.48e-05	0.000382	CbGpPWpGaD
Pranlukast—NFKB1—MyD88 dependent cascade initiated on endosome—IL6—chronic obstructive pulmonary disease	4.46e-05	0.00038	CbGpPWpGaD
Pranlukast—NFKB1—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	4.46e-05	0.00038	CbGpPWpGaD
Pranlukast—NFKB1—TCR Signaling Pathway—IL6—chronic obstructive pulmonary disease	4.38e-05	0.000373	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—CXCL8—chronic obstructive pulmonary disease	4.37e-05	0.000372	CbGpPWpGaD
Pranlukast—IL5—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	4.35e-05	0.00037	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—MMP9—chronic obstructive pulmonary disease	4.33e-05	0.000369	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 9 (TLR9) Cascade—IL6—chronic obstructive pulmonary disease	4.31e-05	0.000367	CbGpPWpGaD
Pranlukast—NFKB1—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	4.31e-05	0.000367	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A2—chronic obstructive pulmonary disease	4.3e-05	0.000366	CbGpPWpGaD
Pranlukast—TNF—Folate Metabolism—IL6—chronic obstructive pulmonary disease	4.28e-05	0.000364	CbGpPWpGaD
Pranlukast—IL5—Immune System—ERBB3—chronic obstructive pulmonary disease	4.25e-05	0.000362	CbGpPWpGaD
Pranlukast—NFKB1—MyD88:Mal cascade initiated on plasma membrane—IL6—chronic obstructive pulmonary disease	4.23e-05	0.00036	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TLR2—chronic obstructive pulmonary disease	4.21e-05	0.000359	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—CXCL8—chronic obstructive pulmonary disease	4.2e-05	0.000358	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	4.19e-05	0.000357	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	4.16e-05	0.000355	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GCLC—chronic obstructive pulmonary disease	4.12e-05	0.00035	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—ADRB2—chronic obstructive pulmonary disease	4.11e-05	0.00035	CbGpPWpGaD
Pranlukast—NFKB1—DNA Damage Response (only ATM dependent)—TP53—chronic obstructive pulmonary disease	4.11e-05	0.00035	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	4.08e-05	0.000348	CbGpPWpGaD
Pranlukast—NFKB1—MyD88-independent cascade—IL6—chronic obstructive pulmonary disease	4.06e-05	0.000346	CbGpPWpGaD
Pranlukast—TNF—Alzheimers Disease—TP53—chronic obstructive pulmonary disease	4.05e-05	0.000345	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—EDN1—chronic obstructive pulmonary disease	4.05e-05	0.000345	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL1B—chronic obstructive pulmonary disease	4.03e-05	0.000343	CbGpPWpGaD
Pranlukast—NFKB1—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	3.97e-05	0.000338	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—KL—chronic obstructive pulmonary disease	3.96e-05	0.000337	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	3.95e-05	0.000336	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—VEGFA—chronic obstructive pulmonary disease	3.92e-05	0.000334	CbGpPWpGaD
Pranlukast—IL5—Immune System—CRP—chronic obstructive pulmonary disease	3.89e-05	0.000331	CbGpPWpGaD
Pranlukast—NFKB1—Senescence-Associated Secretory Phenotype (SASP)—IL6—chronic obstructive pulmonary disease	3.87e-05	0.00033	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	3.87e-05	0.00033	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR ligand binding—CXCL8—chronic obstructive pulmonary disease	3.87e-05	0.00033	CbGpPWpGaD
Pranlukast—CYSLTR1—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—chronic obstructive pulmonary disease	3.86e-05	0.000328	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—chronic obstructive pulmonary disease	3.85e-05	0.000328	CbGpPWpGaD
Pranlukast—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—chronic obstructive pulmonary disease	3.85e-05	0.000328	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—TNF—chronic obstructive pulmonary disease	3.84e-05	0.000327	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—CXCL8—chronic obstructive pulmonary disease	3.83e-05	0.000326	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—KL—chronic obstructive pulmonary disease	3.8e-05	0.000324	CbGpPWpGaD
Pranlukast—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—chronic obstructive pulmonary disease	3.8e-05	0.000324	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by Interleukins—IL6—chronic obstructive pulmonary disease	3.79e-05	0.000323	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.77e-05	0.000321	CbGpPWpGaD
Pranlukast—IL5—Immune System—TLR4—chronic obstructive pulmonary disease	3.73e-05	0.000318	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—ADIPOQ—chronic obstructive pulmonary disease	3.69e-05	0.000314	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EDN1—chronic obstructive pulmonary disease	3.68e-05	0.000313	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL1B—chronic obstructive pulmonary disease	3.67e-05	0.000313	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—KL—chronic obstructive pulmonary disease	3.67e-05	0.000312	CbGpPWpGaD
Pranlukast—NFKB1—Activated TLR4 signalling—IL6—chronic obstructive pulmonary disease	3.65e-05	0.000311	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TGFB1—chronic obstructive pulmonary disease	3.6e-05	0.000306	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—RAPGEF3—chronic obstructive pulmonary disease	3.59e-05	0.000306	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TGFB1—chronic obstructive pulmonary disease	3.57e-05	0.000304	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—HTR2A—chronic obstructive pulmonary disease	3.54e-05	0.000302	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	3.53e-05	0.000301	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—EGFR—chronic obstructive pulmonary disease	3.5e-05	0.000298	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—TNF—chronic obstructive pulmonary disease	3.5e-05	0.000298	CbGpPWpGaD
Pranlukast—NFKB1—Downstream signaling events of B Cell Receptor (BCR)—EGFR—chronic obstructive pulmonary disease	3.48e-05	0.000296	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	3.47e-05	0.000296	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	3.46e-05	0.000295	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—IL1B—chronic obstructive pulmonary disease	3.46e-05	0.000295	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	3.46e-05	0.000295	CbGpPWpGaD
Pranlukast—NFKB1—Toll Like Receptor 4 (TLR4) Cascade—IL6—chronic obstructive pulmonary disease	3.44e-05	0.000293	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	3.41e-05	0.000291	CbGpPWpGaD
Pranlukast—TNF—Selenium Micronutrient Network—IL6—chronic obstructive pulmonary disease	3.4e-05	0.00029	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	3.39e-05	0.000288	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—EGFR—chronic obstructive pulmonary disease	3.32e-05	0.000283	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—TGFB1—chronic obstructive pulmonary disease	3.3e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—CXCL8—chronic obstructive pulmonary disease	3.3e-05	0.000281	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TNF—chronic obstructive pulmonary disease	3.3e-05	0.000281	CbGpPWpGaD
Pranlukast—TNF—TNF alpha Signaling Pathway—IL6—chronic obstructive pulmonary disease	3.28e-05	0.000279	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—HTR2A—chronic obstructive pulmonary disease	3.22e-05	0.000274	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	3.19e-05	0.000271	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Breast Cancer Pathway—TP53—chronic obstructive pulmonary disease	3.16e-05	0.00027	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	3.12e-05	0.000266	CbGpPWpGaD
Pranlukast—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—chronic obstructive pulmonary disease	3.12e-05	0.000266	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—VEGFA—chronic obstructive pulmonary disease	3.11e-05	0.000265	CbGpPWpGaD
Pranlukast—NFKB1—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	3.1e-05	0.000264	CbGpPWpGaD
Pranlukast—NFKB1—B Cell Activation—EGFR—chronic obstructive pulmonary disease	3.07e-05	0.000262	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—CD8A—chronic obstructive pulmonary disease	3.06e-05	0.000261	CbGpPWpGaD
Pranlukast—NFKB1—Toll-Like Receptors Cascades—IL6—chronic obstructive pulmonary disease	3.06e-05	0.000261	CbGpPWpGaD
Pranlukast—IL5—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	3.05e-05	0.00026	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	3.03e-05	0.000258	CbGpPWpGaD
Pranlukast—TNF—Toll-like Receptor Signaling Pathway—IL6—chronic obstructive pulmonary disease	3.02e-05	0.000257	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL1B—chronic obstructive pulmonary disease	3.02e-05	0.000257	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—LEP—chronic obstructive pulmonary disease	3.01e-05	0.000256	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TNF—chronic obstructive pulmonary disease	2.97e-05	0.000253	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—ERBB3—chronic obstructive pulmonary disease	2.97e-05	0.000253	CbGpPWpGaD
Pranlukast—IL5—Hemostasis—TP53—chronic obstructive pulmonary disease	2.96e-05	0.000252	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—TP53—chronic obstructive pulmonary disease	2.94e-05	0.00025	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—GC—chronic obstructive pulmonary disease	2.93e-05	0.000249	CbGpPWpGaD
Pranlukast—NFKB1—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	2.91e-05	0.000247	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	2.89e-05	0.000246	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—ERBB3—chronic obstructive pulmonary disease	2.85e-05	0.000243	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	2.85e-05	0.000242	CbGpPWpGaD
Pranlukast—NFKB1—Myometrial Relaxation and Contraction Pathways—IL6—chronic obstructive pulmonary disease	2.84e-05	0.000242	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	2.83e-05	0.000241	CbGpPWpGaD
Pranlukast—NFKB1—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.82e-05	0.00024	CbGpPWpGaD
Pranlukast—ABCC2—NRF2 pathway—TGFB1—chronic obstructive pulmonary disease	2.81e-05	0.000239	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	2.77e-05	0.000236	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	2.75e-05	0.000234	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTT1—chronic obstructive pulmonary disease	2.75e-05	0.000234	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—PDE4A—chronic obstructive pulmonary disease	2.72e-05	0.000232	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GCLC—chronic obstructive pulmonary disease	2.71e-05	0.000231	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—CRP—chronic obstructive pulmonary disease	2.71e-05	0.000231	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TGFB1—chronic obstructive pulmonary disease	2.69e-05	0.000229	CbGpPWpGaD
Pranlukast—TNF—Spinal Cord Injury—IL6—chronic obstructive pulmonary disease	2.69e-05	0.000229	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—VEGFA—chronic obstructive pulmonary disease	2.68e-05	0.000228	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—TP53—chronic obstructive pulmonary disease	2.68e-05	0.000228	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	2.65e-05	0.000226	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	2.65e-05	0.000225	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—VEGFA—chronic obstructive pulmonary disease	2.64e-05	0.000225	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—EGFR—chronic obstructive pulmonary disease	2.64e-05	0.000225	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—KL—chronic obstructive pulmonary disease	2.63e-05	0.000224	CbGpPWpGaD
Pranlukast—NFKB1—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2.62e-05	0.000223	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	2.62e-05	0.000223	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—TLR4—chronic obstructive pulmonary disease	2.6e-05	0.000222	CbGpPWpGaD
Pranlukast—NFKB1—Fc epsilon receptor (FCERI) signaling—IL6—chronic obstructive pulmonary disease	2.55e-05	0.000217	CbGpPWpGaD
Pranlukast—CYP2C9—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	2.51e-05	0.000214	CbGpPWpGaD
Pranlukast—TNF—Adipogenesis—IL6—chronic obstructive pulmonary disease	2.49e-05	0.000212	CbGpPWpGaD
Pranlukast—CYP2C9—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	2.48e-05	0.000211	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—LEP—chronic obstructive pulmonary disease	2.46e-05	0.00021	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR2—chronic obstructive pulmonary disease	2.45e-05	0.000209	CbGpPWpGaD
Pranlukast—NFKB1—Cellular Senescence—IL6—chronic obstructive pulmonary disease	2.45e-05	0.000209	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	2.43e-05	0.000207	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TGFB1—chronic obstructive pulmonary disease	2.43e-05	0.000207	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL1B—chronic obstructive pulmonary disease	2.43e-05	0.000207	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—EGFR—chronic obstructive pulmonary disease	2.38e-05	0.000203	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—HMOX1—chronic obstructive pulmonary disease	2.37e-05	0.000201	CbGpPWpGaD
Pranlukast—TNF—Apoptosis—TP53—chronic obstructive pulmonary disease	2.36e-05	0.000201	CbGpPWpGaD
Pranlukast—TNF—Regulation of toll-like receptor signaling pathway—IL6—chronic obstructive pulmonary disease	2.36e-05	0.000201	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—KL—chronic obstructive pulmonary disease	2.31e-05	0.000196	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—LEP—chronic obstructive pulmonary disease	2.29e-05	0.000195	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP1A2—chronic obstructive pulmonary disease	2.28e-05	0.000194	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—EGFR—chronic obstructive pulmonary disease	2.26e-05	0.000193	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP1A2—chronic obstructive pulmonary disease	2.25e-05	0.000192	CbGpPWpGaD
Pranlukast—TNF—MAPK Signaling Pathway—TP53—chronic obstructive pulmonary disease	2.21e-05	0.000189	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCR2—chronic obstructive pulmonary disease	2.19e-05	0.000187	CbGpPWpGaD
Pranlukast—CYSLTR1—GPCR downstream signaling—CXCL8—chronic obstructive pulmonary disease	2.19e-05	0.000186	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	2.17e-05	0.000185	CbGpPWpGaD
Pranlukast—TNF—SIDS Susceptibility Pathways—IL6—chronic obstructive pulmonary disease	2.15e-05	0.000183	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—TP53—chronic obstructive pulmonary disease	2.02e-05	0.000172	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	2.02e-05	0.000172	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—APIP—chronic obstructive pulmonary disease	2.02e-05	0.000172	CbGpPWpGaD
Pranlukast—TNF—Integrated Pancreatic Cancer Pathway—TP53—chronic obstructive pulmonary disease	2e-05	0.00017	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—CXCL8—chronic obstructive pulmonary disease	1.99e-05	0.000169	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.97e-05	0.000168	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.93e-05	0.000164	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTP1—chronic obstructive pulmonary disease	1.9e-05	0.000162	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.9e-05	0.000162	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTP1—chronic obstructive pulmonary disease	1.88e-05	0.00016	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CD8A—chronic obstructive pulmonary disease	1.86e-05	0.000158	CbGpPWpGaD
Pranlukast—NFKB1—Cellular responses to stress—IL6—chronic obstructive pulmonary disease	1.85e-05	0.000158	CbGpPWpGaD
Pranlukast—IL5—Immune System—EGFR—chronic obstructive pulmonary disease	1.85e-05	0.000157	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.84e-05	0.000157	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.81e-05	0.000154	CbGpPWpGaD
Pranlukast—NFKB1—Cytokine Signaling in Immune system—IL6—chronic obstructive pulmonary disease	1.77e-05	0.000151	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1.77e-05	0.00015	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—GSTM1—chronic obstructive pulmonary disease	1.75e-05	0.000149	CbGpPWpGaD
Pranlukast—NFKB1—Signaling by NGF—IL6—chronic obstructive pulmonary disease	1.74e-05	0.000148	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—ERBB3—chronic obstructive pulmonary disease	1.73e-05	0.000147	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—GSTM1—chronic obstructive pulmonary disease	1.73e-05	0.000147	CbGpPWpGaD
Pranlukast—CYP3A4—Biological oxidations—CYP1A1—chronic obstructive pulmonary disease	1.66e-05	0.000141	CbGpPWpGaD
Pranlukast—CYP3A4—Metapathway biotransformation—CYP1A1—chronic obstructive pulmonary disease	1.64e-05	0.000139	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.64e-05	0.000139	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.62e-05	0.000138	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HDAC2—chronic obstructive pulmonary disease	1.6e-05	0.000137	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—CRP—chronic obstructive pulmonary disease	1.58e-05	0.000135	CbGpPWpGaD
Pranlukast—IL5—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.56e-05	0.000132	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—TLR4—chronic obstructive pulmonary disease	1.52e-05	0.000129	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—KL—chronic obstructive pulmonary disease	1.49e-05	0.000127	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.49e-05	0.000127	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.48e-05	0.000126	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.46e-05	0.000124	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—EGFR—chronic obstructive pulmonary disease	1.45e-05	0.000124	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CTGF—chronic obstructive pulmonary disease	1.44e-05	0.000123	CbGpPWpGaD
Pranlukast—IL5—Immune System—IL6—chronic obstructive pulmonary disease	1.42e-05	0.000121	CbGpPWpGaD
Pranlukast—ABCC2—Transmembrane transport of small molecules—ALB—chronic obstructive pulmonary disease	1.42e-05	0.000121	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—TNF—chronic obstructive pulmonary disease	1.39e-05	0.000118	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	1.39e-05	0.000118	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—MMP9—chronic obstructive pulmonary disease	1.38e-05	0.000117	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ADRB2—chronic obstructive pulmonary disease	1.38e-05	0.000117	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	1.34e-05	0.000114	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—APIP—chronic obstructive pulmonary disease	1.33e-05	0.000114	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A2—chronic obstructive pulmonary disease	1.33e-05	0.000113	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	1.33e-05	0.000113	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	1.32e-05	0.000113	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GC—chronic obstructive pulmonary disease	1.3e-05	0.000111	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—EGFR—chronic obstructive pulmonary disease	1.29e-05	0.00011	CbGpPWpGaD
Pranlukast—NFKB1—Adaptive Immune System—EGFR—chronic obstructive pulmonary disease	1.24e-05	0.000105	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—VEGFA—chronic obstructive pulmonary disease	1.24e-05	0.000105	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EDN1—chronic obstructive pulmonary disease	1.23e-05	0.000105	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	1.22e-05	0.000104	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	1.21e-05	0.000103	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	1.2e-05	0.000102	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	1.17e-05	9.99e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—TGFB1—chronic obstructive pulmonary disease	1.13e-05	9.66e-05	CbGpPWpGaD
Pranlukast—NFKB1—Developmental Biology—IL6—chronic obstructive pulmonary disease	1.12e-05	9.56e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—ERBB3—chronic obstructive pulmonary disease	1.12e-05	9.52e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling by GPCR—IL6—chronic obstructive pulmonary disease	1.12e-05	9.5e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—EGFR—chronic obstructive pulmonary disease	1.11e-05	9.48e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—HTR2A—chronic obstructive pulmonary disease	1.08e-05	9.16e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	1.06e-05	9.04e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—TP53—chronic obstructive pulmonary disease	1e-05	8.55e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—LEP—chronic obstructive pulmonary disease	1e-05	8.52e-05	CbGpPWpGaD
Pranlukast—NFKB1—Innate Immune System—IL6—chronic obstructive pulmonary disease	9.91e-06	8.44e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL1B—chronic obstructive pulmonary disease	9.86e-06	8.4e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—chronic obstructive pulmonary disease	9.65e-06	8.22e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	9.53e-06	8.12e-05	CbGpPWpGaD
Pranlukast—IL5—Signaling Pathways—IL6—chronic obstructive pulmonary disease	9.19e-06	7.82e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—RAPGEF3—chronic obstructive pulmonary disease	8.84e-06	7.53e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	8.75e-06	7.45e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GC—chronic obstructive pulmonary disease	8.6e-06	7.32e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	8.58e-06	7.31e-05	CbGpPWpGaD
Pranlukast—TNF—Developmental Biology—IL6—chronic obstructive pulmonary disease	8.55e-06	7.28e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALDH7A1—chronic obstructive pulmonary disease	7.99e-06	6.81e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—SERPINE1—chronic obstructive pulmonary disease	7.85e-06	6.68e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—EGFR—chronic obstructive pulmonary disease	7.51e-06	6.4e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—NOS3—chronic obstructive pulmonary disease	7.49e-06	6.38e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	7.2e-06	6.13e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTT1—chronic obstructive pulmonary disease	7.12e-06	6.06e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GCLC—chronic obstructive pulmonary disease	7.04e-06	5.99e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—CXCL8—chronic obstructive pulmonary disease	6.65e-06	5.66e-05	CbGpPWpGaD
Pranlukast—CYSLTR1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	6.59e-06	5.61e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism of lipids and lipoproteins—ALB—chronic obstructive pulmonary disease	6.56e-06	5.59e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CTGF—chronic obstructive pulmonary disease	6.42e-06	5.47e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—MMP9—chronic obstructive pulmonary disease	6.01e-06	5.12e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1A2—chronic obstructive pulmonary disease	5.92e-06	5.04e-05	CbGpPWpGaD
Pranlukast—NFKB1—Immune System—IL6—chronic obstructive pulmonary disease	5.77e-06	4.92e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—VEGFA—chronic obstructive pulmonary disease	5.4e-06	4.6e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TGFB1—chronic obstructive pulmonary disease	4.95e-06	4.22e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTP1—chronic obstructive pulmonary disease	4.94e-06	4.2e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—HMOX1—chronic obstructive pulmonary disease	4.87e-06	4.15e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—EGFR—chronic obstructive pulmonary disease	4.86e-06	4.14e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTT1—chronic obstructive pulmonary disease	4.7e-06	4e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GCLC—chronic obstructive pulmonary disease	4.64e-06	3.95e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—GSTM1—chronic obstructive pulmonary disease	4.54e-06	3.86e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—CYP1A1—chronic obstructive pulmonary disease	4.3e-06	3.66e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CTGF—chronic obstructive pulmonary disease	4.24e-06	3.61e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—TP53—chronic obstructive pulmonary disease	4.08e-06	3.47e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1A2—chronic obstructive pulmonary disease	3.9e-06	3.32e-05	CbGpPWpGaD
Pranlukast—NFKB1—Signaling Pathways—IL6—chronic obstructive pulmonary disease	3.73e-06	3.18e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTP1—chronic obstructive pulmonary disease	3.25e-06	2.77e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—HMOX1—chronic obstructive pulmonary disease	3.21e-06	2.73e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—GSTM1—chronic obstructive pulmonary disease	2.99e-06	2.55e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—ALB—chronic obstructive pulmonary disease	2.92e-06	2.49e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—CYP1A1—chronic obstructive pulmonary disease	2.84e-06	2.41e-05	CbGpPWpGaD
Pranlukast—CYP2C9—Metabolism—NOS3—chronic obstructive pulmonary disease	2.8e-06	2.38e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—ALB—chronic obstructive pulmonary disease	1.93e-06	1.64e-05	CbGpPWpGaD
Pranlukast—CYP3A4—Metabolism—NOS3—chronic obstructive pulmonary disease	1.84e-06	1.57e-05	CbGpPWpGaD
